Literature DB >> 19897286

Green tea extract decreases muscle pathology and NF-kappaB immunostaining in regenerating muscle fibers of mdx mice.

Nicholas P Evans1, Jarrod A Call, Josep Bassaganya-Riera, John L Robertson, Robert W Grange.   

Abstract

BACKGROUND & AIMS: Duchenne muscular dystrophy is a debilitating genetic disorder characterized by severe muscle wasting and early death in afflicted boys. The primary cause of this disease is mutations in the dystrophin gene resulting in massive muscle degeneration and inflammation. The purpose of this study was to determine if dystrophic muscle pathology and inflammation were decreased by pre-natal and early dietary intervention with green tea extract.
METHODS: Mdx breeder mice and pups were fed diets containing 0.25% or 0.5% green tea extract and compared to untreated mdx and C57BL/6J mice. Serum creatine kinase was assessed as a systemic indicator of muscle damage. Quantitative histopathological and immunohistochemical techniques were used to determine muscle pathology, macrophage infiltration, and NF-kappaB localization.
RESULTS: Early treatment of mdx mice with green tea extract significantly decreased serum creatine kinase by approximately 85% at age 42 days (P< or =0.05). In these mice, the area of normal fiber morphology was increased by as much as approximately 32% (P< or =0.05). The primary histopathological change was a approximately 21% decrease in the area of regenerating fibers (P< or =0.05). NF-kappaB staining in regenerating muscle fibers was also significantly decreased in green tea extract-treated mdx mice when compared to untreated mdx mice (P< or =0.05).
CONCLUSION: Early treatment with green tea extract decreases dystrophic muscle pathology potentially by regulating NF-kappaB activity in regenerating muscle fibers. Copyright 2009 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19897286      PMCID: PMC2882522          DOI: 10.1016/j.clnu.2009.10.001

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  41 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 2.  Do immune cells promote the pathology of dystrophin-deficient myopathies?

Authors:  M J Spencer; J G Tidball
Journal:  Neuromuscul Disord       Date:  2001-09       Impact factor: 4.296

3.  A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice.

Authors:  John D Porter; Sangeeta Khanna; Henry J Kaminski; J Sunil Rao; Anita P Merriam; Chelliah R Richmonds; Patrick Leahy; Jingjin Li; Wei Guo; Francisco H Andrade
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

4.  Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species.

Authors:  Timo M Buetler; Mathilde Renard; Elizabeth A Offord; Heinz Schneider; Urs T Ruegg
Journal:  Am J Clin Nutr       Date:  2002-04       Impact factor: 7.045

Review 5.  Function and genetics of dystrophin and dystrophin-related proteins in muscle.

Authors:  Derek J Blake; Andrew Weir; Sarah E Newey; Kay E Davies
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

Review 6.  Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis.

Authors:  T A Rando
Journal:  Microsc Res Tech       Date:  2001-11-15       Impact factor: 2.769

7.  Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle.

Authors:  John D Porter; Wei Guo; Anita P Merriam; Sangeeta Khanna; Georgiana Cheng; Xiaohua Zhou; Francisco H Andrade; Chellah Richmonds; Henry J Kaminski
Journal:  Neuromuscul Disord       Date:  2003-03       Impact factor: 4.296

8.  Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.

Authors:  S Armando Villalta; Hal X Nguyen; Bo Deng; Tomomi Gotoh; James G Tidball
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

9.  A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.

Authors:  M Wehling; M J Spencer; J G Tidball
Journal:  J Cell Biol       Date:  2001-10-01       Impact factor: 10.539

10.  A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium.

Authors:  Philip C Chen; Derek S Wheeler; Vivek Malhotra; Kelli Odoms; Alvin G Denenberg; Hector R Wong
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

View more
  25 in total

Review 1.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

2.  Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial.

Authors:  C-L Shen; M-C Chyu; J K Yeh; Y Zhang; B C Pence; C K Felton; J-M Brismée; B H Arjmandi; S Doctolero; J-S Wang
Journal:  Osteoporos Int       Date:  2011-07-16       Impact factor: 4.507

3.  Fatty acid profile of cardiac muscle phospholipid and triacylglycerol in MDX mice and C57BL/10ScSnJ controls.

Authors:  Marc A Tuazon; Gregory C Henderson
Journal:  Lipids       Date:  2013-06-22       Impact factor: 1.880

4.  Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice.

Authors:  Tony Huynh; Kitipong Uaesoontrachoon; James L Quinn; Kathleen S Tatem; Christopher R Heier; Jack H Van Der Meulen; Qing Yu; Mark Harris; Christopher J Nolan; Guy Haegeman; Miranda D Grounds; Kanneboyina Nagaraju
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

Review 5.  Emerging drugs for Duchenne muscular dystrophy.

Authors:  Vinod Malik; Louise R Rodino-Klapac; Jerry R Mendell
Journal:  Expert Opin Emerg Drugs       Date:  2012-06       Impact factor: 4.191

Review 6.  Nutrition strategies to improve physical capabilities in Duchenne muscular dystrophy.

Authors:  J Davoodi; C D Markert; K A Voelker; S M Hutson; Robert W Grange
Journal:  Phys Med Rehabil Clin N Am       Date:  2011-12-13       Impact factor: 1.784

Review 7.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

8.  Green tea component EGCG, insulin and IGF-1 promote nuclear efflux of atrophy-associated transcription factor Foxo1 in skeletal muscle fibers.

Authors:  Robert J Wimmer; Sarah J Russell; Martin F Schneider
Journal:  J Nutr Biochem       Date:  2015-08-10       Impact factor: 6.048

Review 9.  Current and Emerging Therapies for Duchenne Muscular Dystrophy.

Authors:  Megan Crone; Jean K Mah
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

10.  (-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury.

Authors:  Waleed M Renno; May Al-Maghrebi; Anwar Al-Banaw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.